Bilimsel çalışmalar

Uzm. Dr. Taner Coşkuner

43 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Paediatric neuro-Behçet's disease: multi-centre observational study

    Rheumatology (Oxford, England), 2026

    DOI 10.1093/rheumatology/keag187 PMID 41968830 Kaynak: Europe PMC

  2. Biological therapies in paediatric Behçet’s disease: results of an international collaborative study by the PRES Vasculitis Working Party

    Rheumatology, 2026

    DOI 10.1093/rheumatology/keaf404 PMID 40748718 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  3. A Single-Center Study on Childhood Rare Vasculitides: Clinical and Outcome Analysis

    Turkish archives of pediatrics, 2026

    DOI 10.65717/turkarchpediatr.2025.25316 PMID 42084883 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  4. Real-world efficacy, safety, and drug retention of anakinra and canakinumab in paediatric colchicine-resistant familial Mediterranean fever: Insights from a single-centre cohort

    Modern Rheumatology, 2026

    DOI 10.1093/mr/roag015 PMID 41721725 1 atıf (OpenAlex) Kaynak: OpenAlex

  5. Mycoplasma pneumoniae enfeksiyonu geçiren çocukların klinik laboratuvar ve radyolojik bulgularının değerlendirilmesi

    Ümraniye Pediatri Dergisi - Journal of Umraniye Pediatrics, 2026

    DOI 10.14744/upd.2026.20591 Açık erişimli tam metinKaynak: OpenAlex

  6. Comparison of the Clinical Expression of Patients with Enthesitis/Spondylitis-Related Juvenile Idiopathic Arthritis (E/SpRJIA) from Türkiye and India

    Archives of Rheumatology, 2026

    DOI 10.5152/archrheumatol.2026.25122 Açık erişimli tam metinKaynak: OpenAlex

  7. Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf221 PMID 40257440 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Results of a Nationwide Multicenter Study in Childhood Sjögren Disease

    The Journal of Rheumatology, 2025

    DOI 10.3899/jrheum.2024-1048 PMID 40664482 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  9. Differentiating Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Using Blood Composite Scores: Insights into Clinical Outcomes and Predictive Indices

    Pediatric Cardiology, 2025

    DOI 10.1007/s00246-025-03785-w PMID 39875620 8 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  10. Multidimensional assessment of Juvenile Sjögren disease

    Clinical rheumatology, 2025

    DOI 10.1007/s10067-025-07486-w PMID 40447911 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  11. Preliminary Evaluation for the Development of a Scoring System to Predict Homozygous M694V Genotype in Familial Mediterranean Fever Patients: A Single-Center Study

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2025

    DOI 10.1097/rhu.0000000000002165 PMID 39705124 6 atıf (Europe PMC) Kaynak: Europe PMC

  12. The enigma of familial Mediterranean fever: phenotypic characterization of patients harbouring variants of uncertain significance

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf139 PMID 40067091 6 atıf (OpenAlex) Kaynak: OpenAlex

  13. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-023-00943-3 PMID 38167070 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  14. Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-024-01047-2 PMID 39695685 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  15. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or-6 therapy

    Rheumatology, 2024

    DOI 10.1093/rheumatology/keae124 PMID 38441301 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  16. Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)

    The Journal of experimental medicine, 2024

    DOI 10.1084/jem.20240699 PMID 39576310 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  17. Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)

    Newcastle University ePrints (Newcastle Univesity), 2024

    DOI 10.25405/ncl.34521243 Açık erişimli tam metinKaynak: OpenAlex

  18. Evaluation of epicardial adipose tissue thickness and carotid intima-media thickness in children with Behçet's disease

    Clinical and Experimental Rheumatology, 2024

    DOI 10.55563/clinexprheumatol/ghk2ya PMID 39263800 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  19. Cost-saving approach with screening of selected variants in genetic diagnosis in Turkish pediatric familial Mediterranean fever patients: a single center longitudinal study

    The Turkish Journal of Pediatrics, 2024

    DOI 10.24953/turkjpediatr.2024.4580 PMID 39387426 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  20. Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06802-6 PMID 37926798 9 atıf (Europe PMC) Kaynak: OpenAlex

  21. The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06557-0 PMID 36826737 10 atıf (Europe PMC) Kaynak: OpenAlex

  22. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

    Expert Opinion on Biological Therapy, 2023

    DOI 10.1080/14712598.2023.2282133 PMID 37970654 7 atıf (Europe PMC) Kaynak: OpenAlex

  23. PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

    Modern Rheumatology, 2023

    DOI 10.1093/mr/road008 PMID 36680425 1 atıf (Europe PMC) Kaynak: OpenAlex

  24. Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry

    Rheumatology, 2023

    DOI 10.1093/rheumatology/kead496 PMID 37725366 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  25. Analysis of IFN-γR1 (CD119) and IL-12Rβ1 (CD212) Deficiency by Flow Cytometry,IFN-γRI (CD119) ve IL-12Rβ1 (CD212) Eksikliğinin Akan Hücre Ölçer ile Analizi

    Mikrobiyoloji Bulteni, 2023

    DOI 10.5578/mb.20239907 PMID 36636848 Açık erişimli tam metinKaynak: ORCID

  26. Not easy-peasy to diagnose: familial Mediterranean fever unaccompanied by fever

    European Journal of Pediatrics, 2023

    DOI 10.1007/s00431-023-05061-6 PMID 37380818 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  27. Safety and efficacy of biologic therapies in refractory/severe pediatric behçet’s disease: an international cohort

    Kocaeli Üniversitesi - AVESİS, 2023

    Kaynak: OpenAlex

  28. Erysipelas-like Erythema: A Pathognomonic Rash in Children with Familial Mediterranean Fever

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2023

    DOI 10.4274/bmj.galenos.2023.2023.3-23 5 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  29. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry

    Rheumatology, 2023

    DOI 10.1093/rheumatology/kead242 PMID 37228026 26 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  30. Refrakter/Ağır Pediatrik Behçet Hastalığında Biyolojik Tedavilerin Güvenliği ve Etkinliği: Uluslararası Kohort Değerlendirmesi

    Kocaeli Üniversitesi - AVESİS, 2023

    Kaynak: OpenAlex

  31. Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort

    Frontiers in Pediatrics, 2022

    DOI 10.3389/fped.2021.805919 PMID 35127599 59 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  32. Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases

    Expert Opinion on Biological Therapy, 2022

    DOI 10.1080/14712598.2022.2123703 PMID 36101926 11 atıf (Europe PMC) Kaynak: OpenAlex

  33. Cluster analysis of paediatric Behçet’s disease: Data from The Pediatric Rheumatology Academy-Research Group

    Modern Rheumatology, 2022

    DOI 10.1093/mr/roac044 PMID 35534229 12 atıf (Europe PMC) Kaynak: OpenAlex

  34. AB1264 CLINICAL, DEMOGRAPHIC CHARACTERISTICS AND TREATMENT RESPONSES OF PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.5013 Açık erişimli tam metinKaynak: OpenAlex

  35. POS1272 EVALUATION OF DIAGNOSIS, TREATMENT AND OUTCOME RESULTS OF MIS-C PATIENTS

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.4837 Açık erişimli tam metinKaynak: OpenAlex

  36. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04980-7 PMID 34491393 51 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  37. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center

    Postgraduate Medicine, 2021

    DOI 10.1080/00325481.2021.1987732 PMID 34605352 17 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  38. Clinical course of COVID-19 in children with rheumatic disease under biologic therapy.

    PubMed, 2021

    PMID 33634781 7 atıf (Europe PMC) Kaynak: OpenAlex

  39. POS1181 CLINICAL COURSE OF COVID-19 IN CHILDREN WITH RHEUMATIC DISEASE UNDER BIOLOGIC THERAPY

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.1173 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  40. POS0630 COMPARISON OF THE EFFICACY AND SAFETY OF ORIGINAL AND BIOSIMILAR ADALIMUMAB MOLECULES IN CHILDHOOD RHEUMATIC DISEASES

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.2979 1 atıf (OpenAlex) Kaynak: OpenAlex

  41. POS0082 PERFORMANCES OF THE RISK FACTORS AND PEDIATRIC VASCULITIS ACTIVITY SCORES FOR DISEASE SEVERITY IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.2916 Kaynak: OpenAlex

  42. POS1319 RAYNAUD'S PHENOMENON IN A SINGLE CENTER COHORT OF TURKISH CHILDREN

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.3076 Kaynak: OpenAlex

  43. SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    The Journal of Experimental Medicine, 2021

    DOI 10.1084/jem.20210446 PMID 33904890 146 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex